2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia

Annals of Clinical Psychiatry

Volumn 13, Issue 2, 2001, Pages 63-67

  Mavissakalian, M R ^a,b   Perel, J M ^c  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

2nd year; Agoraphobia; Imipramine; Maintenance; Panic disorder; Relapse

Indexed keywords

IMIPRAMINE;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; TREATMENT OUTCOME;

AGORAPHOBIA; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMIPRAMINE; MALE; PANIC DISORDER; RECURRENCE;

EID: 0034876412     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016699922670     Document Type: Article

References (6)

1. Long-term maintenance and discontinuation of imipramine therapy in panic disorder
2. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia
3. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia
4. A rating scale for depression
5. Brief standard self-rating for phobic patients
6. Rational treatment of panic disorders with antidepressants